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ABSTRACTS
of the International Scientific Meeting: News in Ophthalmology
NEW DEVELOPMENTS IN ANTERIOR KERATOPLASTY
Jesper Hjortdal
Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark
Anterior keratoplasty has been a surgical option for treatment of cornea dis-
eases located to the corneal stroma, such as keratoconus, stromal corneal dys-
trophies and corneal scars after keratitis. Earlier, anterior keratoplasty was per-
formed by manual dissection of the diseased corneal stroma. The interface often 
caused scarring and impaired visual acuity. 
During the last decades improvement of surgical techniques, introduction 
of femtosecond lasers and new surgical approaches have expanded the surgical 
options and improved the outcome anterior lamellar keratoplasty.
Today, dissection can be performed at the interface between stroma and Des-
cemet’s membrane, reducing interface scarring significantly, femtosecond lasers 
can be used to make superficial anterior lamellar keratoplasty an easy proce-
dure without the need for suturing, and intrastromal implantation of corneal 
implants can also be used to treat keratoconus. The presentation will update on 
current and coming techniques, including the possibilities for using synthetic 
tissues for anterior keratoplasty. 
Keywords: anterior lamellar keratoplasty; corneal scars; keratoconus; cor-
neal dystrophy.
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REGENERATION OF THE OCULAR SURFACE USING 
BIOMATERIALS AND MODIFICATION OF THE CORNEA
Thomas Fuchsluger
Department of Ophthalmology, Friedrich-Alexander-University, 
Erlangen-Nurenberg, Germany
Background: Amniotic membranes have been used for many years for re-
construction of the ocular surface. Despite having anti-inflammatory and anti-
angiogenic properties as well as being suitable as a carrier for corneal epithelial 
cells, amniotic membranes also have some limitations for use at the human cor-
nea: availability is limited, there are major interindividual variations in structure 
and growth factor content and are not free from the risk of disease transmission. 
Progress in tissue engineering has been made aiming at the development and 
improvement of alternative biomaterials. 
Objectives: This article presents new approaches for reconstruction of the 
corneal surface with collagen-based biomaterials and polymers. 
Material and methods: Electronic databases were searched for articles which 
evaluated collagenous biomaterials for use at the corneal surface. In addition, 
the authors’ own experiences with novel biomaterials are described. 
Results: In vitro evaluation of the described biomaterials suggested a high 
biocompatibility with corneal epithelial cells in cell cultures. In vivo experi-
ments with these materials in animal corneas demonstrated a certain variability 
in degradation and remodelling. Although some materials showed promising 
experimental results none of these are established in the clinical routine and 
only few clinical studies have so far been conducted with collagen-based bio-
materials. 
Conclusion: Although the majority of the described biomaterials are cur-
rently still in the experimental stage, a transfer into the clinical routine is con-
ceivable and of great therapeutic interest. A range of alternatives to human 
donor tissue for corneal transplantation are being developed to address the 
shortfall of good quality tissues as well as the clinical conditions in which allo-
grafting is contraindicated. Classical keratoprostheses, more commonly referred 
to as artificial corneas have been around and are being used clinically to replace 
minimal corneal function, but only as last resorts, as they are still associated 
with significant in vivo complications, such as extrusion/rejection, glaucoma, 
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or retinal detachment. In the past few years, there have been many significant 
developments in technologies that are designed to replace part or the full thick-
ness of damaged or diseased corneas that encourages regeneration to different 
extents. In this review, we describe selected examples from the range of these 
corneal substitutes that range from keratoprostheses with regenerative capabili-
ties through tissue-engineered scaffolds pre-seeded with stem cells to cell-based 
regenerative strategies. It is unlikely that there will be one best corneal substi-
tute for all indications, but taken together, the various approaches may soon be 
able to supplement the supply of human donor corneas for transplantation or 
allow restoration of diseased or damaged corneas that cannot be treated by cur-
rently available techniques.
Keywords: corneal surface reconstruction; collagen-based biomaterials; cell-
based regenerative therapy.
THE EYE AND THE GUT: TWO SIDES OF THE SAME 
IMMUNOLOGICAL COIN
Carolina Arancibia
Translational Gastroenterology Unit, University of Oxford, Oxford, UK
The topic of this talk was presentation of commonalities and disparities be-
tween the eye and the intestine from an immunological point of view.
The main objective of presented research work was to show how we can 
translate basic research results in mucosal immunology treatments for chronic 
diseases, specifically inflammatory bowel disease, liver disease and cancer into 
a basic research in eye immunology. In particular, research results focusing in 
characterizing the mucosal microenvironment and how it affects host cells were 
presented.
In addition, during the lecture we saw results of a sample biobank manage-
ment and results of immunological research in a cohort of patients with gastro-
intestinal disorders and cancers.
Keywords: immunology of intestine; eye immunology; immune privilege.
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DEVELOPMENT OF OPHTHALMOLOGY IN REGION – 
BUSINESS MODELS
Nikica Gabrić
Special Eye Hospital “Svjetlost”, Department of Ophthalmology, 
University of Rijeka, Zagreb, Croatia
Main change in the development of ophthalmology in the region was founda-
tion of private clinics in Croatia and the region. As an example, foundation and 
growth of a private eye hospital Svjetlost was presented. The hospital is based 
on the “one-day surgery” model in which it is possible to treat all eye diseases 
that require surgical treatment - laser vision correction, ultrasound cataract sur-
gery, surgery on the back of the eye due to disease caused by diabetes, diseases 
of macula or degenerative changes of the retina, surgical treatment of glaucoma 
(elevated intraocular pressure), surgical treatment of strabismus (squint), plastic 
and reconstructive surgery on eyelids, and corneal transplants with a shortest 
stay in the hospital. For almost all eye surgeries patients stay for half an hour 
after the surgery and are able to go home. However, there is also medical unit 
with hospital beds in Svjetlost, just for cases that require intensive care or for pa-
tients which underwent complex surgical procedures and thus need prolonged 
monitoring. Soon after its foundation, Svjetlost clinic became one of the first pri-
vate university clinic in Croatia with the parent institution situated in Zagreb. 
Later on, Svjetlost branches were opened also in Split (Croatia) and in several in 
neighbouring countries: in Sarajevo and Banja Luka (Bosnia and Herzegovina), 
Budva (Montenegro), Novi Sad (Serbia) and  in collaboration with local hospitals 
in Skopje (Macedonia); and soon its opening its offices in Priština (Kosovo) and 
Tirana (Albania).
Special Hospital for Ophthalmology Svjetlost believes in the education and 
training of young people and every year employees several new doctors who 
get a possibility to specialize in ophthalmology. In addition to having their costs 
of specialization fully covered, these doctors have the option of going to a pres-
tigious global conference and to visit most famous ophthalmological centres, 
where they can acquire new knowledge and always be in step with the latest de-
velopments in the profession. Mainly due to its well-designed business model, 
Special Eye Hospital Svjetlost became the leading ophthalmic institution in the 
region that provides a comprehensive service. It is known for the highest stan-
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dards of technical support and knowledge and constantly proves to be a repre-
sentative of the latest technology in ophthalmologic practice. 
Keywords: ophthalmology business model; private clinic; one-day surgery.
TRANSPLANTATION OF CORNEAL LIMBAL STEM 
CELLS CULTIVATED IN VITRO
Iva Dekaris
Special Eye Hospital “Svjetlost”, Department of Ophthalmology, 
University of Rijeka, Zagreb, Croatia
Transplantation of corneal limbal stem cells is a successful treatment for pa-
tients with partial or total limbal stem cell deficiency caused by ocular combus-
tion. This method of treatment is known since 1970-ies and is currently per-
formed at only a few European ophthalmological centres. Namely, in case of 
corneal burn, limbal stem cells are destroyed and corneal conjunctivalisation 
and opacification occurs. In such cases conventional corneal transplantation 
cannot succeed since normal epithelialization of the grafted corneas is impos-
sible without limbal stem cells. Current and best available treatment for such pa-
tients is to take a small (2 mm) sample of limbal stem cells from the contralateral 
healthy eye, cultivate them in vitro on the amniotic membrane (or some other 
scaffold) in a tissue bank and then, once the sufficient number of limbal stem 
cells is cultivated, transplantation of these cells onto a diseases eye. In some 
cases, transplantation of limbal stem cells alone is sufficient treatment and no 
further action is needed. In cases where visual improvement is not adequate, 
corneal transplantation may be performed several months after limbal stem cell 
transplantation, and in such cases corneal graft will survive since limbal stem 
cells are provided previously. In the Special Eye Hospital “Svjetlost” we have 
started with this method of treatment in 2016, as first regional hospital provid-
ing this sophisticated treatment to patients with previously untreatable corneal 
diseases. We have presented results of first cases, young patients with corneal 
combustion caused by lime, tear gas and explosive burn, which were blind to 
an eye for a previous at least 5-10 years. All three cases recovered their vision 
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significantly and did not needed corneal transplantation as a second step pro-
cedure at all.
Keywords: limbal stem-cell transplantation; corneal combustion; in vitro cul-
tivation of limbal stem cells; amniotic membrane scaffold.
SYNTHETIC VS NATURAL SCAFFOLDS FOR HUMAN 
LIMBAL STEM CELLS
Mirna Tominac-Trcin
Tissue Bank, Traumatology Hospital, 
University Hospital „Sestre Milosrdnice“, Zagreb, Croatia
Aim: To investigate the impact of synthetic electrospun polyurethane (PU) 
and polycaprolactone (PCL) nano-scaffolds, before and after hydrolytic surface 
modification, on viability and differentiation of cultured human eye epithelial 
cells, in comparison with natural scaffolds: fibrin and human amniotic mem-
brane.
Methods: Human placenta was taken at elective caesarean delivery. Fibrin 
scaffolds were prepared from commercial fibrin glue kits. Nano scaffolds were 
fabricated by electrospinning. Limbal cells were isolated from surpluses of hu-
man cadaveric cornea and seeded on feeder 3T3 cells. The scaffolds used for 
viability testing and immunofluorescence analysis were amniotic membrane, 
fibrin, PU, and PCL nano-scaffolds, with or without prior NaOH treatment.
Results: Scanning electron microscope photographs of all tested scaffolds 
showed good colony spreading of seeded limbal cells. There was a significant 
difference in viability performance between cells with highest viability cultured 
on tissue culture plastic and cells cultured on all other scaffolds. On the other 
hand, electrospun PU, PCL, and electrospun PCL treated with NaOH had more 
than 80% of limbal cells positive for stem cell marker p63 compared to only 
27%of p63 positive cells on fibrin.
Conclusion: Natural scaffolds, fibrin and amniotic membrane, showed better 
cell viability than electrospun scaffolds. On the contrary, high percentages of 
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p63 positive cells obtained on these scaffolds still makes them good candidates 
for efficient delivery systems for therapeutic purposes.
Keywords: natural scaffolds; electrospun polyurethane; nan-scaffolds; p63 
positive cells; limbal stem cells.
NOVEL ANTIFIBROTICS IN CORNEAL WOUND 
HEALING
Tomislav Šarenac
Department of Ophthalmology, University Hospital Maribor, Maribor, Slovenia
Corneal wound healing is often affected by TGF-β–mediated fibrosis and 
scar formation. Guided fibrosis with IGF-1 and antifibrotic substances might 
maintain corneal transparency. Primary human corneal keratocytes under se-
rum-free conditions were used as a model of corneal stromal wounding, with 
markers of corneal fibrosis and opacity studied under TGF-β2 stimulation. 
Single-cell imaging flow cytometry was used to determine nuclearization of 
Smad3, and intracellular fluorescence intensity of Smad7 and the corneal crys-
tallin aldehyde dehydrogenase 3A1. Extracellular matrix proteoglycans kerato-
can and biglycan were quantified using ELISAs. On the TGF-β2 background, 
the keratocytes were treated with IGF-1, and suberoylanilidehydroxamic acid 
(SAHA) or halofuginone ± IGF-1. IGF-1 alone decreased Smad3 nuclearization 
and increased aldehyde dehydrogenase 3A1 expression, with favourable extra-
cellular matrix proteoglycan composition. SAHA induced higher Smad7 levels 
and inhibited translocation of Smad3 to the nucleus, also when combined with 
IGF-1. Immunofluorescence showed that myofibroblast trans-differentiation is 
attenuated and appearance of fibroblasts is favoured by IGF-1 alone and in com-
bination with the antifibrotic substances. The TGF-β/Smad pathway of fibrosis 
and opacity was inhibited by IGF-1, and further with SAHA in particular, and 
with halofuginone. IGF-1 is thus a valid aid to antifibrotic treatment, with poten-
tial for effective and transparent corneal wound healing.
Keywords: corneal wound healing; TGF- β, IGF-1; antifibrotic treatment.
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THE ROLE OF PROANGIOGENIC CYTOKINES AND 
THEIR RECEPTORS IN NEOVASCULARIZATION OF 
CORNEAL GRAFT
Maja Pauk-Gulić, Nikica Gabrić, Iva Dekaris
Special Eye Hospital “Svjetlost”, Department of Ophthalmology, 
University of Rijeka, Zagreb, Croatia
Purpose: To evaluate correlation of vascular endothelial growth factor 
(VEGF) and its soluble receptors quantity in the recipient cornea at the time of 
penetrating keratoplasty (PK) and its potential influence on graft rejection. 
Methods: Study included 60 eyes scheduled for PK, equally distributed by 
corneal pathology into 3 risks groups: low, medium, high and controls. Quantity 
of VEGF-A and C, sVEGFR-1, R2 and R3 was analysed in total cornea and its 
layers using an enzyme-linked immunosorbent assay; correlated and compared 
with neovascularization rate and frequency of graft reaction/rejection in 2 post-
operative years. 
Results: Highest concentrations of VEGF-A and C in total cornea were in 
high risk cases (599 pg/ml; 8.49 ng/ml) and the lowest in controls (102 pg/ml; 
5.23ng/ml). Soluble VEGFR-1 and sVEGFR-3 were significantly higher in low risk 
patients (2.11 ng/ml; 1.62 ng/ml) as compared to high risk group in total cornea 
(1.8 ng/ml; 0.63 ng/ml). There were 2 graft rejections, both in high risk group. 
Eyes with graft reaction had significantly higher VEGF-A (477 pg/ml) and VEGF-
C (6.06 ng/ml) and lower sVEGFR-1 (2.23 ng/ml) and R3 (0.49 ng/ml) as compared 
to clear grafts. Statistical analysis was done by Kruskal-Wallis ANOVA non-
parametric test and difference between groups was analysed by Mann-Whitney 
U-test.
Conclusion: Our data implicate that graft reaction occurs more often in cor-
neas with increased VEGF-A and C and decreased sVEGFR-1 and R3. Novelty is 
that soluble VEGF receptors in human corneas may suppress rejection acting as 
a VEGF-sink, and potentially serve as anti-rejection therapy.
Keywords: penetrating keratoplasty; vascular endothelial growth factor; sol-
uble VEGF receptors; human corneas; corneal neovascularization; graft survival 
rate.
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PREMIUM CATARACT AND REFRACTIVE LENS 
EXCHANGE SURGERY WITH EXTENDED DEPTH OF 
FOCUS INTRAOCULAR LENSES
Ante Barišić, Neven Miličić, Iva Dekaris, Maja Bohač, Nikica Gabrić
Special Eye Hospital “Svjetlost”, Department of Ophthalmology, 
University of Rijeka, Zagreb, Croatia
Cataract surgery is more and more becoming refractive surgery. Patients de-
mand excellent vision at all distances without wearing glasses or contact lenses. 
Modern technology and lens designs are enabling ophthalmologists fulfilling of 
increased patient’s expectations.
In Eye Hospital Svjetlost, Zagreb, Croatia in last two years around one third 
of patients who had PHACO surgery got presbyopia correcting intraocular lens-
es in their eyes. Multifocal intraocular lenses (MFIOL) enable high level of spec-
tacle independence but have high rate of halo and glare in night driving.
The newest generation of presbyopia correcting intraocular lenses (IOL) is so 
called Extended Depth of Focus (EDOF) lenses.  EDoF IOLs represent a new cat-
egory of intraocular lenses, combining benefits of different technologies. They 
have a wider range of clear vision than monofocal IOLs and fewer side effects 
than multifocal IOLs.
There are a few different designs of EDoF IOLs. 
AT LARA (Carl Zeiss Meditec AG) is aspheric, diffractive intraocular lens 
with extended depth of focus. It gives spectacle independence for intermedi-
ate and far distances and less visual side effects than multifocal IOL. It has an 
aberration-neutral aspheric design and advanced chromatic correction for better 
contrast sensitivity. Patients have to wear glasses for reading a small print.
Mini Well Ready IOL (Sifi Medtech) is the first progressive multifocal 
aspheric IOL for the presbyopia correction. It has three optical zones with differ-
ent spherical aberrations. Among the optical zones there are smooth transition 
areas, thanks to which a good vision at all distances is achieved without halos.
Small aperture IC-8 IOL (AcuFocus) is a one-piece hydrophobic acrylic IOL 
with an embedded black circular mask. The mask blocks unfocused rays of 
light, extending depth of focus and providing patients with good visual acuity 
across a range of distances. The lens is implanted in the nondominant eye but 
does not create monovision.
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Tecnis Symfony extended range of vision IOL is a diffractive IOL with elon-
gated focus and achromatic technology which enhances contrast sensitivity. 
This lens enables continuous vision from far to near, less halos compared to 
MFIOLs, better contrast sensitivity and high level of spectacle independence. 
Still, some patients have to wear glasses for small print. Tecnis Symfony can be 
viable option for post LASIK patients, amblyopes, patients with mild macular 
pathology and patients with monofocal IOL in first eye.
EDOF IOLs represent a new generation of presbyopia correcting lenses with 
better quality of vision and fewer visual disturbances but poorer uncorrected near 
visual acuity compared to MFIOLs. The choice of the IOL must be made according 
to patient’s lifestyle, job and everyday activities.
Keywords: extended range of vision lens; multifocal lens; refractive lens ex-
change.
EXCIMER LASER TREATMENT OF IRREGULAR 
CORNEAS
Maja Bohač, Mateja Končarević, Nikica Gabrić
Special Eye Hospital “Svjetlost”, Department of Ophthalmology,
University of Rijeka, Zagreb, Croatia
Purpose: To evaluate efficacy and safety of ocular or corneal wavefront guid-
ed transepithelial photorefractive keratectomy (transPRK), alone or in combina-
tion with corneal collagen crosslinking (CXL), in treatment of irregular astigma-
tism.
Patients and methods: 10 cases (10 patients) with iatrogenic cause of irregu-
lar astigmatism (e.g corneal scars caused by previous infection or injury) and 
17 cases (14 eyes) of corneal ectasia (either keratoconus or post LASIK ectasia) 
were treated. Follow up was from 3 months up to 3 years. Corneal or ocular 
wave-front guided treatment was used depending on ablation plan and amount 
of tissue needed for excimer laser ablation. For ectatic cases CXL was performed 
simultaneously with either 3 or 10 mW/cm2 lamp.  
Results: In both groups there was no statistically significant improvement 
in uncorrected distance visual acuity (group I p=0.06, group II p= 45). Corrected 
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distance visual acuity significantly improved (p<0.001), together with all high 
order aberrations (p<0.001). There were no complications with corneal epitheli-
alization which lasted in average for 5 days. Transient mild haze was noticed in 
all cases, 5 cases from group II have permanent mild haze without influence on 
visual acuity. 2 cases (1 eye post LASIK ectasia and 1 eye keratoconus) are expe-
riencing progressive flattening for up to 3 years after the treatment.
Conclusion:  Wavefront guided treatments are efficient in regularizing ante-
rior corneal surface. Additional caution and more patients with longer follow up 
are needed to prove its safety in treatment of ectatic corneas.  
Keywords: excimer laser; irregular corneas; transPRK; corneal crosslinking.
OVERVIEW OF MULTIFOCAL IOLS USED IN SVJETLOST 
HOSPITAL
Adis Pašalić, Iva Dekaris, Nikica Gabrić, Ante Barišić
Special Eye Hospital “Svjetlost”, Department of Ophthalmology, 
University of Rijeka, Zagreb, Croatia
Purpose: To make systematic review of the numbers and types of multifocal 
intraocular lenses implanted in our clinic, importance of good patient’s selec-
tion, preoperative assessment and selection of the proper intraocular lens along 
with the limitations of the lens design.
Methods: Prospective, consecutive, interventional case series. The study 
analysed different types of multifocal intraocular lenses implanted in patients 
underwent surgeries in Special eye hospital „Svjetlost “in period 2005-2017. All 
surgeries were done by experienced surgeons and on the same phaco machine. 
Patient selection based on their needs, professions, demands as well as type of 
refraction has been included in the study. We follow-up patients up to 5 years, vi-
sual acuity, postoperative change in refraction and adverse events were recorded.
Results. In period of 2005-2012 we implanted: „ReSTORE +4“ intraocular 
lenses in 344 eyes, Tecnis ZM900 & ZMA00 & ZB00 in 610 eyes, „ReZoom“ in 
160 eyes, „AcryLisa & AT LISA 809 MP“  in 536 eyes and Mix and Match has 
been used in 440 eyes.
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In period of 2013 till 2017 we implanted „new“ MF for refractive lens ex-
change. In total we included 1844 eyes, out of that number „Symfony lens has 
been implanted in 632 eyes, „Technis low-add“ lenses in 396 eyes, „Acriva Reviol 
Tri-Focal lenses in 130 eyes, „PanOptix“ in 44 eyes and other MF in 60 eyes. Dur-
ing 12 years follow-up time we made learned about advantages and insufficien-
cies of different lens type and design.
Conclusion. There is no important difference in visual acuity between Re-
stor and Tecnis IOL apart from low-light conditions where Tecnis acrylic do 
better. Patients with ReZoom lenses have better intermediate vision then Re-
stor and Tecnis but lack good near vision. Patient with bilateral ReZoom lenses 
have more night-time driving difficulties then Restor and Tecnis patients. Mix 
and Match group: highly satisfied (75%) or highly unsatisfied (25%). There is no 
significant differences in visual acuity between „new“ MF intraocular lenses, 
though „Symfony“ can be used in patients with amblyopia.
Keywords: intraocular lens; multifocal; phaco; patient selection.
AVELLINO DNA TEST FOR REFRACTIVE SURGERY 
SAFETY
Mateja Končarević, Iva Dekaris
Special Eye Hospital “Svjetlost”, Department of Ophthalmology, 
University of Rijeka, Zagreb, Croatia
Nowadays with high patient expectations and tremendous technology im-
provements, refractive surgery stands for one of the most safe and predictable 
surgical procedures. The biggest fear for most surgeons is postoperative corneal 
ectasia. The prevalence of this condition is about 1 in 2000 eyes, comparable with 
prevalence of keratoconus in the general population. Advanced corneal topog-
raphy systems make it easier for clinicians to identify patients at increased risk 
of postsurgical ectasia, but the condition can still go undetected preoperatively. 
On the other hand, there is another possible complication that doesn’t come in 
mind so often or can easily be overlooked. Another potential complication after 
laser vision correction is the exacerbation of some types of corneal dystrophy 
like granular (GCD) type 1 (GCD1) or type 2 (GCD2).  Currently, when we gener-
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ally speak about dystrophies, their classification is based on the affected layer 
of the cornea, with differing phenotypic presentations that affect different cor-
neal layers, there is obviously a question about the genetic background of those 
disorders. The specific genetic mutation in combination with some sort of tis-
sue damage will produce the classic phenotypic appearance of each of the dys-
trophies. Dystrophies are caused by genetic mutations of transforming growth 
factor beta (TGF-β)–induced gene, which is associated with the wound-healing 
process of the cornea. TGFBIp is one of the most common proteins in the hu-
man cornea. While it is not fully understood, it is believed that it plays a critical 
role in important functions such as regulating cellular adhesions and migration 
within the cornea and binding with other macromolecules in the extracellular 
matrix, especially collagen.  One of its most important functions is thought to be 
during wound healing.  After corneal injury the expression of TGFBI protein is 
upregulated in keratocytes near the wound. Dystrophies are autosomal domi-
nant. Those who carry the gene for the condition will exhibit the phenotype, 
though the age. While homozygous patients start to lose visual acuity at a young 
age, those with the heterozygous condition may develop visual acuity loss later 
in life. Since the global prevalence of heterozygous TGFB1- dystrophies appears 
to be greater than that of keratoconus, therefore patients undergoing laser vision 
correction may be at higher risk of developing TGFB1- dystrophies than corneal 
ectasia. There have been cases reported across the globe, with first larger study 
launched in Korea, published as high prevalence of GCD2, genetic testing has 
quickly become the standard of care. Today, there has been performed more 
than 500 000 refractive surgery safety DNA tests with Avellino genetic test and 
identified more than 550 patients with inherited corneal dystrophies, protect-
ing them from accelerated vision loss. Twice as prevalent as keratoconus, it has 
become evident that testing for Corneal Dystrophies is becoming the standard 
of care in the many countries. Testing for 5 corneal dystrophy gene mutations 
identifies LASIK candidates at risk of post-surgery complications so that refrac-
tive surgeons can offer non-surgical alternatives for those patients.
Materials and methods: We tested two different families with Avellino ge-
netic test, one family with previous family history of keratoplasty with suspect 
GCD1, and one with previous history of refractive surgery with suspect GCD2. 
Within all family members, buccal swab was taken and specimens were sent to 
Avellino Labs. For genetic testing.
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Results: In GCD1 family only one member was negative to genetic testing, 
and two members with worst clinical appearance were tested as homozygous. 
In GCD2 family all members were tested as heterozygous.
Conclusion: In many cases, the identification of a specific mutation will pro-
vide more accurate information about the course or progression of the condition 
and patients’ response to surgical intervention. Genetic testing such as Avellino 
genetic test for refractive safety should provide information that will help clini-
cians to correctly diagnose dystrophy and molecular genetics will ensure the 
possibility of therapeutic intervention with drugs or gene therapy to prevent or 
delay the need for more invasive surgical treatment.
Keywords: Avellino test; corneal dystrophy; TGFB1-dystrophies; corneal ec-
tasia; refractive surgery; genetic testing.
NEW TREATMENTS FOR DIABETIC RETINOPATHY 
TESTED IN CLINICAL STUDIES
Ratimir Lazic, MD, PhD
Special Eye Hospital “Svjetlost”, Department of Ophthalmology, 
University of Rijeka, Zagreb, Croatia
Numerous clinical studies have confirmed the significance of antiVEGF 
treatment for diabetic retinopathy (DR) and diabetic macular oedema (DME). 
Other than antiVEGF, laser photocoagulation, corticosteroids such as triamcino-
lone or Ozurdex are used in treatment  or  pars plana vitrectomy (PPV) in more 
severe cases.  The Diabetic Retinopathy Clinical Research Network (DRCR.net) 
have confirmed that patient who received ranibizumab + differed laser had the 
most significant results gaining most letters in ETDRS chart, followed by ra-
nibizumab +prompt laser, sham + laser, and triamcinolone +laser at the primary 
outcome point at 52nd week of the study. Mean change in central foveolar thick-
ness (CFT) from the baseline was followed by the same pattern: with group of 
ranibizumab + differed laser being the best and triamcinolone and laser being 
the last group with even increase of CFT at week 104 of the study. VISTA-DME 
and VIVID-DME studies were 2 multicentric randomised studies which showed 
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in Phase III of the study the superiority of aflibercept (Eylea) as compared to 
laser therapy, which led Eylea to be approved for DME in 2014. DRCR.net has 
recently published protocol T study about the relative efficacy and safety of 
intravitreal aflibercept, bevacizumab, and ranibizumab for treating eyes with 
DME and concluded that aflibercept, bevacizumab, or ranibizumab improved 
vision in eyes with DME, but the relative effect depended on baseline visual 
acuity. When the initial visual-acuity loss was mild, there were no apparent 
differences, on average, among study groups. At worse levels of initial visual 
acuity, aflibercept was more effective at improving vision. Other factors that 
have been studied and published in research are placental growth factor (PGF) 
which was showed in blocked PGF mice to prevent loss of pericytes, capillary 
permeability and degeneration (Huang H et al. Diabetes, 2014). The RISE and 
RIDE studies has expanded the approved use for ranibizumab injection to treat 
DR in patients with DME which gave approval to patients with DR and DME 
the first significant therapy to treat this vision-impairing complication. Other 
novel agents and studies which are currently ongoing include: antiVEGF +squal-
amine, antiVEGF+Tie2, CRaf inhibitors and anti-integrins. We can conclude that 
pharmacotherapy in DME treatment will be eventually combined of different 
agents with antiVEGF being so far the main approach and must not be given in 
low dosage. The laser will always have its place in combined pharmacotherapy 
treatment with PPV reserved for the most severe cases of proliferative DR.  
Keywords: diabetic retinopathy; diabetic macular oedema; antiVEGF; phar-
macotherapy; pars plana vitrectomy.
RANIBIZUMAB FOR NAMD: NEW EVIDENCE TO 
IMPROVE PATIENT CARE
Damir Bosnar
University Eye Clinic, University Hospital „Sveti Duh”, Zagreb
Josip Juraj Strossmayer University of Osijek
Purpose: To report results of TREND and Rival study results. 
Design: TREND Study is a  12-month phase 3b visual acuity (VA) assessor-
masked, multicenter, randomized, interventional study which evaluate the ef-
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ficacy and safety of ranibizumab 0.5 mg treat-and-extend (T&E) versus month-
ly regimens in patients with neovascular age-related macular degeneration 
(nAMD). RIVAL Study is a 24-month, randomised, multi-centre Phase IV study 
which compare the rate of development of geographic atrophy after 24 months 
in nAMD patients treated with 0.5 mg ranibizumab and 2.0 mg aflibercept using 
a ‘Treat and Extend’ regimen (T&E). Results from a 12-month interim analysis of 
pre-specified key secondary endpoints (number of injections and change in Best 
Corrected Visual Acuity (BCVA) from baseline to Month 12), are presented here 
Methods: In TREND study treatment-naïve nAMD patients (age, ≥50 years) 
were randomized 1:1 to receive either a ranibizumab 0.5 mg T&E (n = 323) or 
monthly (n = 327) regimen while in RIVAL Study eyes were randomised (1:1) 
to receive intravitreal injections of either 0.5 mg ranibizumab (RBZ) or 2.0 mg 
aflibercept (AFL). After receiving three initial monthly injections, patients en-
tered the T&E phase which allowed for extension up to 12-weekly injections by 
2 weekly increments if the CNV was considered inactive as per protocol. The 
pre-planned 12-month interim analysis was done.
Results: TREND Study showed noninferiority of T&E regimen (P < 0.001) to 
the monthly regimen, with a mean BCVA change from baseline of 6.2 versus 8.1 
letters to the end of study, respectively. The mean change in CSFT from baseline 
to the end of study was -169.2 µm and -173.3 µm in the T&E and monthly groups, 
respectively. Fewer injections were required in patients receiving the T&E (8.7) 
versus monthly (11.1) regimen with comparable rates of adverse events between 
the treatment groups. RIVAL Study included 278 patients. The mean BCVA at 
month 12 was 72.9 letters in the RBZ arm (n=127, SD=15.5 [5-95]), and 70.5 letters 
in the AFL arm (n=121, SD=14.6 [36-91]). The change from baseline at Month 12 
was +6.93 (95% CI: 5.20 to 8.65) for RBZ and +4.41 (95% CI: 2.64 to 6.18) for AFL. 
In patients who withdrew from the study before Month 12, the mean BCVA at 
the time of withdrawal [mean change from baseline] was 66.1 letters [+7.1] for 
RBZ (n=14; 9.9%) and 64.8 letters [+2.0] for AFL (n=16; 11.7%). The mean number 
of injections from baseline to Month 12 was 9.7 injections in both the RBZ (n=141; 
SD=2.77 [1-13]) and AFL arms (n=137; SD=2.55 [3-13]). 
Conclusions: In TREND Study ranibizumab 0.5 mg administered according 
to a T&E regimen was comparable with a monthly regimen in improving VA 
from baseline to the end results. RIVAL study for the first time in T&E dosing 
regimen in nAMD patients showed significant visual acuity improvements by 
month 12 with both ranibizumab (+6.93 letters) and aflibercept (+4.41 letters) and 
similar mean number of injections received over the first 12 months.
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Keywords: TREND study; RIVAL study; ranibizumab; neovascular age-re-
lated macular degeneration.
SYSTEMIC INFLAMMATION IN DIABETES IS 
ASSOCIATED WITH RETINOPATHY DEVELOPMENT IN 
TYPE 2 BUT NOT IN TYPE 1 DIABETES
Martina Tomić
Department of Ophthalmology, Vuk Vrhovac University Clinic for Diabetes, Endo-
crinology and Metabolic Diseases, Merkur University Hospital, Zagreb, Croatia
Purpose. Diabetic retinopathy (DR), a microvascular and visually devastat-
ing diabetic complication, is the leading cause of new blindness among working-
age adults in developed countries. Its pathogenesis is insufficiently understood 
and presumed to possibly involve chronic, low-grade inflammation. The aim 
of this study was to investigate risk factors and role of systemic inflammation 
and obesity in development of retinopathy in type 1 and type 2 diabetes and 
determine the differences in these two types of disease, with possible impact on 
future research and treatment guidelines.
Methods. This cross-sectional study included 84 patients with type 1 and 107 
patients with type 2 diabetes. Basic and anthropometric parameters assessed 
were sex, age, diabetes duration, body mass index (BMI), waist circumference 
(WC) and waist-to-hip ratio (WHR). C-reactive protein (CRP), fibrinogen (FIB), 
glycated haemoglobin (HbA1c), fasting and postprandial blood glucose (fBG, 
ppBG), total cholesterol, HDL and LDL cholesterol, triglycerides (TG) and se-
rum creatinine were determined using routine laboratory methods. HbA1cmedian 
was obtained by statistical analysis of data from the National Diabetes Registry. 
Glomerular filtration rate was estimated using CKD-EPI formula. Albumin ex-
cretion rate (AER) was measured from a 24-hr urine sample. Blood pressure was 
measured with a mercury sphygmomanometer after a 10-min resting period. 
Ophthalmologic examination included indirect slit lamp fundoscopy and colour 
fundus photography after mydriasis of two fields of both eyes according to the 
EURODIAB retinal photography methodology.
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Results. Patients were divided into three groups: group 1 (no retinopathy), 
group 2 (mild/moderate NPDR) and group 3 (severe NPDR/PDR). In both types 
of diabetes group 3 had longer diabetes duration than group 1 (type 1 p=0.002; 
type 2 p<0.001). Group 3 in type 1 had higher HbA1cmedian (p<0.001) and AER 
(p=0.002), while in type 2 had higher BMI, WC, WHR, SBP, CRP, FIB, ppBG and 
TG than group 1. DR was positively associated with diabetes duration (p<0.001), 
HbA1cmedian (p<0.001) and AER (0.008) in type 1, and diabetes duration (p<0.001), 
HbA1cmedian (p=0.018), AER (0.001), CRP (p=0.048) and TG (p=0.041) in type 2 dia-
betes. Logistic regression analyses showed that diabetes duration (OR=1.22, CI 
1.04-1.45, p=0.011) and prolonged poor glycaemic control (HbA1cmedian) (OR=1.73, 
CI 1.25-2.34, p=0.022) were the main predictors of DR in type 1 diabetes. Diabe-
tes duration (OR=1.25, CI 1.12-1.39, p<0.001), fBG (OR=1.45, CI 1.04-2.00, p=0.024) 
and TG (OR=2.08, CI 1.09-3.98, p=0.025) were the main predictors of DR in type 
2 diabetes.
Conclusion. Diabetes duration, poor glycaemic control and nephropathy are 
the main risk factors for DR in both types of diabetes. Systemic inflammation 
and visceral obesity were found to be related to the development of DR in type 2 
but not in type 1 diabetes. These findings could purpose different pathogenesis 
of retinopathy in these two different types of diabetes and might therefore sug-
gest different treatment approaches. 
Keywords: diabetic retinopathy; glycaemic control; type 2 diabetes; type 1 
diabetes.
PARS PLANA VITRECTOMY AND INNER RETINAL 
FENESTRATION FOR OPTIC DISC MACULOPATHY-A 
CASE REPORT
Nataša Drača, Ratimir Lazić, Stefan Mladenosvski, Nikica Gabrić
Special Eye Hospital “Svjetlost”, Department of Ophthalmology, 
University of Rijeka, Zagreb, Croatia
Optic disc pits (ODPs) are congenital cavitary anomalies with a pathological 
communication between subarachnoidal and intraretinal and subretinal spaces. 
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When complicated by maculopathy it may cause significant visual deterioration. 
So far multiple approaches for management of ODPs have been used including 
laser photocoagulation, pars plana vitrectomy, macular buckling and intravit-
real gas injection. We present a novel approach of retinal retinotomy combined 
by pars plana vitrectomy (PPV) and gas instillation. 51 yr old patient presented 
with best corrected visual acuity (BCVA) of 0.10 and  ODP maculopathy with 
visible communication between subarachnoidal and intraretinal and subretinal 
spaces confirmed by optical coherent tomography (OCT). We performed par-
tial thickness retinal hole radial to the optic disc and PPV with SF6 gas tam-
ponade.  Macular oedema decreased and communication was closed 3 weeks 
postoperatively.  BCVA, accordingly, increased to 0,25. 2 months postop BCVA 
was still 0,25, even though we noticed slightly increased macular oedema with 
still closed communication of ODP. Inner retinal fenestration enabled to redirect 
flow from subarachnoidal space to vitreous cavity thus closing communication 
and decreasing macular oedema and increasing BCVA of the patient. Howev-
er, even though ODP was closed, we still noticed fluid in macula on 2 months 
control not affecting the BCVA. In literature, patients have been described for 6 
months or even a year of resolving fluid in macula after surgery. This could sug-
gest that there is still occasionally microcommunication between these spaces or 
increased permeability of vessels under the macula. 
Keywords: optic disc maculopathy; retinotomy; pars plana vitrectomy.
SURGICAL TREATMENT OF NYSTAGMUS
Ivana Mravičić, Selma Lukačević, Neven Miličić, Vlade Glavota
Special Eye Hospital “Svjetlost”, Department of Ophthalmology, 
University of Rijeka, Zagreb, Croatia
Nystagmus is an involuntary, periodic eye movement caused by slow drift 
of fixation which is followed by fast refixation. Although the pathologic move-
ment is the slow drift, the direction of nystagmus is defined by the more obvious 
direction of jerk. There are three forms of nystagmus: 1. physiologic nystagmus, 
2. acquired nystagmus caused by some neurological diseases and are not in the 
field of ophthalmologists and 3. Idiopathic infantile nystagmus and ocular nys-
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tagmus caused by some eyes disorders. The nystagmus can be socially embar-
rassing and can be obstacle to good visual acuity.
Although there is no cure for nystagmus in some cases when the patients 
have null-zone achieved with the obvious head turn which is bigger than 10° 
surgery can be done. The aim of the surgery is to shift the null zone of nystagmus 
into primary position. There are several ways to achieve that. One of the most 
popular is Anderson procedure that consists of recession of horizontal recti. If 
the wanted position is not possible to achieve only with recessions Kestenbaum 
method is a good choice. In that surgery we combine recessions with resections 
of desired muscles to put the eyes in the best position. In other cases, were the 
patients preferred head position is head tilt the Kestenbaum method can be used 
on oblique muscles. In the cases where the null zone is in convergence the most 
useful surgery is Y-splitting where we enable the patient to use these position 
for distant vision without head turn. Y-splitting is a method where we split the 
muscle along the 15 mm length and by shortening of affective lever arm reduce 
action of the medial muscle. By performing this surgery, we enable the patient 
to use desired position for distant vision without head turn.
Keywords: nystagmus; Anderson procedure; Kestenbaum method.
CROATIAN NATIONAL PREVENTIVE PROGRAM OF 
EARLY AMBLYOPIA DETECTION
Mirjana Bjeloš, Mladen Bušić, Benedict Rak, Biljana Kuzmanović Elabjer, 
Damir Bosnar, Daliborka Miletić, Senad Ramić
University Hospital ‘Sveti Duh’, Faculty of Medicine, Josip Juraj Strossmayer Uni-
versity of Osijek, University Eye Clinic, Zagreb, Croatia
Aim: To present Croatian National Preventive Program of Early Amblyopia 
Detection, as Croatian contribution to global VISION 2020 initiative launched 
in 1999 promoting the world in which nobody is needlessly visually impaired. 
Methods: Between September 2011 – June 2014 Zagreb Amblyopia Preschool 
Screening (ZAPS) project tested visual acuity of 15,648 children aged 48-54 
months attending kindergartens in the City of Zagreb. Lea Symbols in lines 
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charts were used to test near and distance visual acuity setting the pass cut-off 
level to ≤0.1 logMAR. 78.04% passed the screening, affirming the age-specific 
normative threshold for determining abnormal monocular VA. The estimated 
prevalence of amblyopia in Croatia was 8.08%. Testability rate was 99.19%, with 
sensitivity and specificity of 100.00 % and 96.68%.
Results: Zagreb Amblyopia Preschool Screening study demonstrated am-
blyopia prevalence of 8.08%, which is within earlier reports on the prevalence of 
amblyopia ranging 0.8%-10%. Based on the ZAPS study results, Croatian Minis-
try of Health released National Preventive Program of Early Amblyopia Detec-
tion, mandatory for all 4-year-old children. At the age of 48 months the child is 
referred to an ophthalmologist who performs vision screening by testing visual 
acuity at near (40 cm) and distance (3 m) binocularly and monocularly using Lea 
Symbols in line charts. To facilitate the implementation of National Preventive 
Program of Early Amblyopia Detection and raise awareness among key audi-
ences, Croatian Parliament introduced National Amblyopia Day in 2016, cele-
brating September 12th. Constitution of Croatian National Amblyopia Registry, 
released by Ministry of Health as user friendly on-line application in 2017, was 
of utmost importance to provide high-quality performance of the National Pre-
ventive Program of Early Amblyopia Detection.
Discussion. Comprehensive eye care strategy can be fully generated only by 
actively engaged governmental bodies in collaborative activities of successful 
eye care delivery. 
Conclusion: The World Bank forecasts that the human population will reach 
9.77 billion in 2050. If nothing is done, about 500 million people will be needless-
ly amblyopic world-wide. To rise level of prevention and treatment programs 
we advocate the establishment of national amblyopia registries to acknowledge 
impact of amblyopia more adequately. 
Keywords: Croatian National Preventive Program of Early Amblyopia De-
tection; Vision 20/20; amblyopia.
172
Rad 533. Medical Sciences, 45 (2018) : 151-173
I. Dekaris: Abstracts
WHEN TO OPERATE DUANE SYNDROM?
Neven Miličić
Special Eye Hospital “Svjetlost”, Department of Ophthalmology, 
University of Rijeka, Zagreb, Croatia
Duane syndrome (DS), also known as Duane retraction syndrome (DRS), 
is a rare, congenital disorder of eye movement. Most individuals with Duane 
syndrome are diagnosed by age 10 years. In Duane syndrome, the sixth cranial 
nerve that controls the lateral rectus does not develop properly and this prob-
ably occurs around the sixth week of pregnancy. Lateral rectus muscle is irregu-
larly innervated of a branch from the third cranial nerve, which controls the 
medial rectus muscle and when the eye moves toward the nose, the eyeball pulls 
into the socket (i.e., retraction), There are three types of Duane syndrome. Many 
patients with Duane syndrome develop a habit of turning their face to maintain 
binocular vision and thus compensate for improper turning of the eyes. The 
goal of surgery is the elimination or improvement of an unacceptable head turn. 
In case report there is 11 years old girl with no ability to move left eye outward 
and head is turned to the left. Surgery was performed because of abnormal head 
posture (AHP) with recession of MRM (-5 mm) on the left eye. Duane syndrome 
can be operated only to prevent AHP.
Keywords: Duane syndrome; surgery for Duane syndrome.
FYBROSIS SYNDROME IN NINE-YEAR-OLD GIRL
Selma Lukacevic, Ivana Mravicic
General Hospital Mjeline, Herceg Novi, Montenegro
Special Eye Hospital “Svjetlost”, Zagreb, Croatia
                                                         
Purpose: Successful late treatment results of Congenital Fibrosis of Extra-
ocular Muscles syndrome (CFEOM1).
Methods: Our patient was 9 years old child with a variation of CFEOM1 
syndrome, first presented with abnormal head position (AHP) of 30° chin up. 
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Horizontal movements were normal, both eyes showed no elevation and lim-
ited depression, converging on attempt to elevate and diverging on attempt to 
depress, absent Bell’s phenomenon. She was slightly hypermetropic with no am-
blyopia. Ptosis was significant on both eyes with RE levator muscle function of 6 
mm and no levator function on LE. MRD 1 was 1/ 0 mm. She had compensatory 
frontalis function on both sides. Three surgeries were performed to alleviate 
AHP. During the first strabismus surgery thick fibrotic inferior recti on both 
eyes were recessed. On second strabismus surgery, since the passive motility 
test showed good elevation, anteposition of hypoplastic superior recti situated at 
10 mm behind the limbus was performed. Asymmetric ptosis surgery – frontalis 
suspension was performed on both eyes. 
Results: After two strabismus surgeries AHP improved, but the patient still 
had slight chin up 15°. After ptosis surgery residual AHP was 5°.
Conclusion: Although the best results in treating congenital fibrosis syn-
dromes are achieved by early treatment (e.g.1-2 years old), later treatment can 
also give satisfying results. If no amblyopia present, the most important goal is 
to treat AHP successfully. Because of highly asymmetric and irregular action of 
muscles CFEOM syndromes, special care should be taken for dosage. 
Keywords: congenital fibrosis syndrome; abnormal head position; ptosis 
surgery.
